2022
DOI: 10.1016/j.nicl.2022.102948
|View full text |Cite
|
Sign up to set email alerts
|

Multiscale structural mapping of Alzheimer’s disease neurodegeneration

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 66 publications
0
4
0
Order By: Relevance
“… 42 In a recent report, they combined these microstructural measures based on tissue contrast with macrostructural metrics in a machine-learning framework to demonstrate sensitivity to disease stage. 40 …”
Section: Use Of Traditional Radiomics In Adrd Neuroimagingmentioning
confidence: 99%
“… 42 In a recent report, they combined these microstructural measures based on tissue contrast with macrostructural metrics in a machine-learning framework to demonstrate sensitivity to disease stage. 40 …”
Section: Use Of Traditional Radiomics In Adrd Neuroimagingmentioning
confidence: 99%
“…Neurodegeneration biomarkers, such as hippocampal atrophy and cortical thickness, provide clinicians and researchers with a non‐invasive, feasible, and less expensive option to detect AD. Recent advancements in high‐resolution MRI, as demonstrated by studies conducted by Jang et al ( 2022 ) and Westlye et al ( 2009 ), enable the detection of altered tissue signal properties of brain microstructure even at earlier phases of pathogenesis. These advances in MRI technology can provide additional information on neurodegeneration beyond traditional neurodegeneration biomarkers.…”
Section: Introductionmentioning
confidence: 99%
“…In our recent study, we employed a strategy called multi‐scale structural mapping (MSSM) to combined GWRs obtained from multiple layers of the cortex and subcortical white matter with cortical morphometry maps (i.e., MSSM). This approach allowed us to accurately detect patients with AD dementia as well as individuals with MCI who subsequently progressed to AD dementia within the next 3 years (Jang et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%
“…This often emerges as alterations in memory, analytical thinking, perception, language, mood, and emotions, and eventually impairs physical control over the body. Several studies have been conducted in recent years in an attempt to identify early biomarkers that may be used to assess Alzheimer’s disease risk prior to the onset of symptoms in a speedy and thorough manner 5 7 .…”
Section: Introductionmentioning
confidence: 99%